-
1
-
-
84866256925
-
-
accessed on November 6, 2011
-
Http//www.ibge.gov.br (accessed on November 6, 2011).
-
-
-
-
2
-
-
84866259083
-
-
accessed on November 3, 2011
-
Http:www.ibge.gov.br/home/presidência/noticia-visualiz.php? id-noticia-150 (accessed on November 3, 2011).
-
-
-
-
4
-
-
4043154385
-
Assessment and treatment of lipids in elderly persons
-
Lavie CJ. Assessment and treatment of lipids in elderly persons. Am J Geriatr Cardiol 2004; 13: 2-3.
-
(2004)
Am J Geriatr Cardiol
, vol.13
, pp. 2-3
-
-
Lavie, C.J.1
-
5
-
-
79960250474
-
ESC/EAS Guidelines for the management of dyslipidaemias: The task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)
-
Catapano AL, Reiner Z, De BG, et al. ESC/EAS Guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011; 217 (Suppl 1): S1-S44.
-
(2011)
Atherosclerosis
, vol.217
, Issue.SUPPL. 1
-
-
Catapano, A.L.1
Reiner, Z.2
De, B.G.3
-
6
-
-
21144442794
-
Age-related changes in plaque composition: A study in patients suffering from carotid artery stenosis
-
DOI 10.1016/j.carpath.2005.03.002, PII S1054880705000529
-
van Oostrom O, Velema E, Schoneveld AH, et al. Age-related changes in plaque composition: a study in patients suffering from carotid artery stenosis. Cardiovasc Pathol 2005; 14: 126-134. (Pubitemid 40725588)
-
(2005)
Cardiovascular Pathology
, vol.14
, Issue.3
, pp. 126-134
-
-
Van Oostrom, O.1
Velema, E.2
Schoneveld, A.H.3
De Vries, J.P.P.M.4
De Bruin, P.5
Seldenrijk, C.A.6
De Kleijn, D.P.V.7
Busser, E.8
Moll, F.L.9
Verheijen, J.H.10
Virmani, R.11
Pasterkamp, G.12
-
8
-
-
78449281377
-
Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials
-
Baigent C, Blackwell L, Emberson J, et al. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376: 1670-1681.
-
(2010)
Lancet
, vol.376
, pp. 1670-1681
-
-
Baigent, C.1
Blackwell, L.2
Emberson, J.3
-
9
-
-
79953809941
-
Treatment of dyslipidemia in the elderly
-
Shao H, Chen LQ, Xu J. Treatment of dyslipidemia in the elderly. J Geriatr Cardiol 2011; 8: 55-64.
-
(2011)
J Geriatr Cardiol
, vol.8
, pp. 55-64
-
-
Shao, H.1
Chen, L.Q.2
Xu, J.3
-
10
-
-
84866248928
-
II Brazilian Guidelines of Geriatric Cardiology. Department of Geriatric Cardiology, Brazilian Society of Cardiology
-
Gravina CF, Rosa RF, Franken RA, et al. II Brazilian Guidelines of Geriatric Cardiology. Department of Geriatric Cardiology, Brazilian Society of Cardiology. Arq Bras Cardiol 2010; 95 (3 Suppl 2): S1-S112.
-
(2010)
Arq Bras Cardiol
, vol.95
, Issue.3 SUPPL. 2
-
-
Gravina, C.F.1
Rosa, R.F.2
Franken, R.A.3
-
11
-
-
0344653659
-
Cholesterol-lowering therapy in women and elderly patients with myocardial infarction or angina pectoris: Findings from the Scandinavian Simvastatin Survival Study (4S)
-
Miettinen T, Pyorala K, Olsson A, et al. Cholesterol-lowering theraphy in women and elderly patients with myocardial infarction or angina pectoris. Findings from the Scandinavian Simvastatin Survival Study (4S). Circulation 1997; 96: 4211-4218. (Pubitemid 28007446)
-
(1997)
Circulation
, vol.96
, Issue.12
, pp. 4211-4218
-
-
Miettinen, T.A.1
Pyorala, K.2
Olsson, A.G.3
Musliner, T.A.4
Cook, T.J.5
Faergeman, O.6
Berg, K.7
Pedersen, T.8
Kjekshus, J.9
-
12
-
-
14444271787
-
Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range: Results of the cholesterol and recurrent events (CARE) trial
-
Lewis S, Moye L, Sacks F, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and recurrents events (CARE) trial. Ann Intern Med 1998; 129: 681-689. (Pubitemid 28507140)
-
(1998)
Annals of Internal Medicine
, vol.129
, Issue.9
, pp. 681-689
-
-
Lewis, S.J.1
Moye, L.A.2
Sacks, F.M.3
Johnstone, D.E.4
Timmis, G.5
Mitchell, J.6
Limacher, M.7
Kell, S.8
Glasser, S.P.9
Grant, J.10
Davis, B.R.11
Pfeffer, M.A.12
Braunwald, E.13
-
13
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
DOI 10.1056/NEJM199908053410604
-
Rubins HB, Robins S, Collins D, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 1999; 341: 410-418. (Pubitemid 29362514)
-
(1999)
New England Journal of Medicine
, vol.341
, Issue.6
, pp. 410-418
-
-
Rubins, H.B.1
Robins, S.J.2
Collins, D.3
Fye, C.L.4
Anderson, J.W.5
Elam, M.B.6
Faas, F.H.7
Linares, E.8
Schaefer, E.J.9
Schectman, G.10
Wilt, T.J.11
Wittes, J.12
-
14
-
-
0037031061
-
MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: A randomised placebo-controlled trial
-
MRC/BHF Heart protection study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
-
(2002)
Lancet
, vol.360
, pp. 7-22
-
-
-
15
-
-
0037164314
-
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial
-
DOI 10.1016/S0140-6736(02)11600-X
-
Shepherd J, Blauw G, Murphy M, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet 2002; 360: 1623-1630. (Pubitemid 35379733)
-
(2002)
Lancet
, vol.360
, Issue.9346
, pp. 1623-1630
-
-
Shepherd, J.1
Blauw, G.J.2
Murphy, M.B.3
Bollen, E.L.E.M.4
Buckley, B.M.5
Cobbe, S.M.6
Ford, I.7
Gaw, A.8
Hyland, M.9
Jukema, J.W.10
Kamper, A.M.11
Macfarlane, P.W.12
Meinders, A.E.13
Norrie, J.14
Packard, C.J.15
Perry, I.J.16
Stott, D.J.17
Sweeney, B.J.18
Twomey, C.19
Westendorp, R.G.J.20
more..
-
16
-
-
11144355354
-
Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes
-
DOI 10.1056/NEJMoa040583
-
Cannon CP, Braunwald E, McCabe CH, et al. Comparison of intensive and moderate lipid lowering with statins after acute coronary syndromes. N Eng J Med 2004; 350: 1495-1504. (Pubitemid 38477774)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.15
, pp. 1495-1504
-
-
Cannon, C.P.1
Braunwald, E.2
McCabe, C.H.3
Rader, D.J.4
Rouleau, J.L.5
Belder, R.6
Joyal, S.V.7
Hill, K.A.8
Pfeffer, M.A.9
Skene, A.M.10
-
18
-
-
15944410609
-
Intensive lipid lowering with atorvastatin in patients with stable coronary disease
-
LaRosa J, Grundy S, Waters D, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Med 2005; 352: 14.
-
(2005)
N Engl J Med
, vol.352
, pp. 14
-
-
LaRosa, J.1
Grundy, S.2
Waters, D.3
-
19
-
-
33847171482
-
Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: Results of the Study Assessing Goals in the Elderly (SAGE)
-
DOI 10.1161/CIRCULATIONAHA.106.654756, PII 0000301720070213000007
-
Deedwania P, Stone P, Merz NB, et al. Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: Results of the Study Assessing Goals in the Elderly (SAGE). Circulation 2007; 115: 700-707. (Pubitemid 46294760)
-
(2007)
Circulation
, vol.115
, Issue.6
, pp. 700-707
-
-
Deedwania, P.1
Stone, P.H.2
Merz, C.N.B.3
Cosin-Aguilar, J.4
Koylan, N.5
Luo, D.6
Ouyang, P.7
Piotrowicz, R.8
Schenck-Gustafsson, K.9
Sellier, P.10
Stein, J.H.11
Thompson, P.L.12
Tzivoni, D.13
-
20
-
-
56749106312
-
Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
-
Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008; 359: 2195-2207.
-
(2008)
N Engl J Med
, vol.359
, pp. 2195-2207
-
-
Ridker, P.M.1
Danielson, E.2
Fonseca, F.A.3
-
21
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
DOI 10.1161/01.CIR.0000133317.49796.0E
-
Grundy S, Cleeman J, Merz C, et al. Implications of recent clinical trial for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004; 110: 227-239. (Pubitemid 38924592)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Bairey, M.C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
22
-
-
0037166649
-
Therapy with hydroxymethylglutaryl coenzyme A reductase inhibitors (statins) and associated risk of incident cardiovascular events in older adults: Evidence from the cardiovascular health study
-
Lemaitre R, Psaty B, Heckbert S, et al . Therapy with hydroxymethylglutary Coenzime A reductase inhibitors (Statins) and associated risk of incident cardiovascular events in older adults. evidence from the cardiovascular health study. Arch Intern Med 2002; 162: 1395-1400. (Pubitemid 34655200)
-
(2002)
Archives of Internal Medicine
, vol.162
, Issue.12
, pp. 1395-1400
-
-
Lemaitre, R.N.1
Psaty, B.M.2
Heckbert, S.R.3
Kronmal, R.A.4
Newman, A.B.5
Burke, G.L.6
-
23
-
-
3142729178
-
Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines
-
DOI 10.1161/01.CIR.0000133317.49796.0E
-
Grundy S, Cleeman J, Merz C, et al. Implications of recent clinical trial for the national cholesterol education program adult treatment panel III guidelines. Circulation 2004; 110: 227-239. (Pubitemid 38924592)
-
(2004)
Circulation
, vol.110
, Issue.2
, pp. 227-239
-
-
Grundy, S.M.1
Cleeman, J.I.2
Bairey, M.C.N.3
Brewer Jr., H.B.4
Clark, L.T.5
Hunninghake, D.B.6
Pasternak, R.C.7
Smith Jr., S.C.8
Stone, N.J.9
-
24
-
-
0017384270
-
High density lipoprotein as a protective factor against coronary heart disease. The Framingham study
-
Gordon T, Castelli WP, Hjortland MC, et al. High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study. Am J Med 1977; 62: 707-714. (Pubitemid 8110784)
-
(1977)
American Journal of Medicine
, vol.62
, Issue.5
, pp. 707-714
-
-
Gordon, T.1
Castelli, W.P.2
Hjortland, M.C.3
-
25
-
-
37449021638
-
Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol
-
deGoma EM, Leeper NJ, Heidenreich PA. Clinical significance of high-density lipoprotein cholesterol in patients with low low-density lipoprotein cholesterol. J Am Coll Cardiol 2008; 51: 49-55.
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 49-55
-
-
DeGoma, E.M.1
Leeper, N.J.2
Heidenreich, P.A.3
-
26
-
-
36348975228
-
Effects of torcetrapib in patients at high risk for coronary events
-
DOI 10.1056/NEJMoa0706628
-
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events. N Engl J Med 2007; 357: 2109-2122. (Pubitemid 350146106)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.21
, pp. 2109-2122
-
-
Barter, P.J.1
Caulfield, M.2
Eriksson, M.3
Grundy, S.M.4
Kastelein, J.J.P.5
Komajda, M.6
Lopez-Sendon, J.7
Mosca, L.8
Tardif, J.-C.9
Waters, D.D.10
Shear, C.L.11
Revkin, J.H.12
Buhr, K.A.13
Fisher, M.R.14
Tall, A.R.15
Brewer, B.16
-
27
-
-
33750477286
-
Efficacy and Safety of Torcetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor, in Individuals With Below-Average High-Density Lipoprotein Cholesterol Levels
-
DOI 10.1016/j.jacc.2006.06.067, PII S0735109706019917
-
Davidson MH, McKenney JM, Shear CL, et al. Efficacy and safety of Torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels. J Am Coll Cardiol 2006; 48: 1774-1781. (Pubitemid 44648633)
-
(2006)
Journal of the American College of Cardiology
, vol.48
, Issue.9
, pp. 1774-1781
-
-
Davidson, M.H.1
McKenney, J.M.2
Shear, C.L.3
Revkin, J.H.4
-
28
-
-
78549235583
-
Safety of Anacetrapib in patients with or at high risk for coronary heart disease
-
Cannon CP, Shah S, Dansky HM, et al. Safety of Anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med 2010; 363: 2406-2415.
-
(2010)
N Engl J Med
, vol.363
, pp. 2406-2415
-
-
Cannon, C.P.1
Shah, S.2
Dansky, H.M.3
-
29
-
-
57549090220
-
Intramuscular administration of AAV1-lipoprotein lipase S447X lowers tryglicerides in lipoprotein lipase-deficient patients
-
Stroes ES, Nierman MC, Meulenberg JJ, et al. Intramuscular administration of AAV1-lipoprotein lipase S447X lowers tryglicerides in lipoprotein lipase-deficient patients. Arterioscler Thromb Vasc Biol 2008; 28: 2303-2304.
-
(2008)
Arterioscler Thromb Vasc Biol
, vol.28
, pp. 2303-2304
-
-
Stroes, E.S.1
Nierman, M.C.2
Meulenberg, J.J.3
-
30
-
-
77249100745
-
Safety and tolerability of dalcetrapib: Results from a 48 week trial
-
Stein EA, Roth EM, Rhyne JM, et al. Safety and tolerability of dalcetrapib: results from a 48 week trial. Eur Heart J 2010; 31: 480-488.
-
(2010)
Eur Heart J
, vol.31
, pp. 480-488
-
-
Stein, E.A.1
Roth, E.M.2
Rhyne, J.M.3
-
31
-
-
58649091088
-
Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministred with atorvastatin in dyslipidemic patients
-
Bloomfield D, Carlson GL, Sapre A, et al. Efficacy and safety of the cholesteryl ester transfer protein inhibitor anacetrapib as monotherapy and coadministred with atorvastatin in dyslipidemic patients. Am Heart J 2009; 157: 352-360.
-
(2009)
Am Heart J
, vol.157
, pp. 352-360
-
-
Bloomfield, D.1
Carlson, G.L.2
Sapre, A.3
-
33
-
-
4644255907
-
Thematic review series: The pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part i
-
Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part I. J Lipid Res 2004; 45: 1583-1593.
-
(2004)
J Lipid Res
, vol.45
, pp. 1583-1593
-
-
Steinberg, D.1
-
34
-
-
13944263872
-
An interpretive history of the cholesterol controversy: Part II: The early evidence linking hypercholesterolemia to coronary disease in humans
-
DOI 10.1194/jlr.R400012-JLR200
-
Steinberg D. Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy: Part II: the early evidence linking hypercholesterolemia to coronary disease in humans. J Lipid Res 2005; 46: 179-190. (Pubitemid 40271080)
-
(2005)
Journal of Lipid Research
, vol.46
, Issue.2
, pp. 179-190
-
-
Steinberg, D.1
-
36
-
-
84866259085
-
-
de LM, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon
-
Mediterranean Diet, Traditional Risk Factors, and the Rate of Cardiovascular Complications after Myocardial Infarction: Final Report of the Lyon
-
-
De, L.M.1
Salen, P.2
Martin, J.L.3
-
37
-
-
25444469719
-
An interpretive history of the cholesterol controversy, part III: Mechanistically defining the role of hyperlipidemia
-
DOI 10.1194/jlr.R500010-JLR200
-
Steinberg D. Thematic review series: the pathogenesis of atherosclerosis: an interpretive history of the cholesterol controversy, part III: mechanistically defining the role of hyperlipidemia. J Lipid Res 2005; 46: 2037-2051. (Pubitemid 41377456)
-
(2005)
Journal of Lipid Research
, vol.46
, Issue.10
, pp. 2037-2051
-
-
Steinberg, D.1
-
38
-
-
84866244654
-
Diet Heart Study
-
Diet Heart Study. Circulation 1999; 99: 779-785.
-
(1999)
Circulation
, vol.99
, pp. 779-785
-
-
-
39
-
-
33746858619
-
N-3 fatty acids and cardiovascular disease
-
Breslow JL. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 2006; 83(6 Suppl): S1477-S1482.
-
(2006)
Am J Clin Nutr
, vol.83
, Issue.6 SUPPL.
-
-
Breslow, J.L.1
-
40
-
-
34548729788
-
Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids
-
DOI 10.2459/01.JCM.0000289270.98105.b3, PII 0124466520070900100007
-
Leaf A. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. J Cardiovasc Med (Hagerstown) 2007; 8 (Suppl 1): S27-S29. (Pubitemid 47429078)
-
(2007)
Journal of Cardiovascular Medicine
, vol.8
, Issue.SUPPL. 1
-
-
Leaf, A.1
-
41
-
-
0037161373
-
Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: Time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione
-
DOI 10.1161/01.CIR.0000014682.14181.F2
-
Marchioli R, Barzi F, Bomba E, et al. Early protection against sudden death by n-3 polyunsaturated fatty acids after myocardial infarction: time-course analysis of the results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico (GISSI)-Prevenzione. Circulation 2002; 105: 1897-1903. (Pubitemid 34437615)
-
(2002)
Circulation
, vol.105
, Issue.16
, pp. 1897-1903
-
-
Marchioli, R.1
Barzi, F.2
Bomba, E.3
Chieffo, C.4
Di, G.D.5
Di, M.R.6
Franzosi, M.G.7
Geraci, E.8
Levantesi, G.9
Maggioni, A.P.10
Mantini, L.11
Marfisi, R.M.12
Mastrogiuseppe, G.13
Mininni, N.14
Nicolosi, G.L.15
Santini, M.16
Schweiger, C.17
Tavazzi, L.18
Tognoni, G.19
Tucci, C.20
Valagussa, F.21
more..
|